News
-
-
-
PRESS RELEASE
Terry Lynch Continues as Capital Markets Advisor and BioNxt Retains Investor Relations Professionals
BioNxt Solutions Inc. announces Terry Lynch as capital markets advisor and retention of two investor relations professionals, Rob Grace and Blaine Ruzcki, for promotional activities. Company focuses on bioscience innovations with drug delivery platforms -
-
PRESS RELEASE
Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies
Onco-Innovations announces manufacturing of nanoparticle formulation by Dalton Pharma Services to advance preclinical studies, enhancing clinical readiness in cancer research -
PRESS RELEASE
RE Royalties Announces Cancellation of Previously Announced Non-Brokered Listed Issuer Financing Equity Offering Due to Early Repayment from Clients
RE Royalties cancels private placement offering due to early loan repayments and share price volatility. Company well-capitalized for new opportunities and meeting bond maturity -
-
PRESS RELEASE
GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD
GENFIT discontinues VS-01 program in ACLF and shifts focus to UCD due to safety concerns. The company aims to accelerate other assets in ACLF, while exploring CCA data and reducing operating expenses -
-
PRESS RELEASE
aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year
CEO Rubino Di Girolamo extends contract at aap Implantate AG until 2028; COO Agnieszka Mierzejewska to leave in 2025. Company focuses on new antibacterial technology and strategic realignment
